Migraine Drugs Market Report

Global and Region Migraine Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：220
  • REPORT CODE：GMM922149
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Migraine Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Migraine Drugsmarket, defines the market attractiveness level of Migraine Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Migraine Drugs industry, describes the types of Migraine Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Migraine Drugs market and the development prospects and opportunities of Migraine Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Migraine Drugs market in Chapter 13.

    By Player:

    • Kowa Pharmaceuticals America

    • Johnson & Johnson

    • Eli Lilly

    • Ethypharm

    • Eli Lilly

    • Impax

    • Winston Pharmaceuticals

    • Teva

    • Endo International

    • AstraZeneca

    • Pfizer

    • Merck

    • Abbott

    • GlaxoSmithKline

    • Pfizer

    • Allergan

    By Type:

    • Sumatriptan

    • Zolmitriptan

    • Rizatriptan

    • Other Drug

    By End-User:

    • Hospitals

    • Clinics

    • Household Use

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Migraine Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Migraine Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Migraine Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Migraine Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Migraine Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Migraine Drugs Consumption (2017-2022)

    • 7.2 United States Migraine Drugs Consumption (2017-2022)

    • 7.3 Europe Migraine Drugs Consumption (2017-2022)

    • 7.4 China Migraine Drugs Consumption (2017-2022)

    • 7.5 Japan Migraine Drugs Consumption (2017-2022)

    • 7.6 India Migraine Drugs Consumption (2017-2022)

    • 7.7 South Korea Migraine Drugs Consumption (2017-2022)

    8 Region and Country-wise Migraine Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Migraine Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Migraine Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Migraine Drugs Consumption Forecast (2022-2028)

    • 8.4 China Migraine Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Migraine Drugs Consumption Forecast (2022-2028)

    • 8.6 India Migraine Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Migraine Drugs Consumption Forecast (2022-2028)

    9 Global Migraine Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Migraine Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Sumatriptan Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Zolmitriptan Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Rizatriptan Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Other Drug Consumption and Growth Rate (2017-2022)

    • 9.2 Global Migraine Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Household Use Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Migraine Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Migraine Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Sumatriptan Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Zolmitriptan Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Rizatriptan Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Other Drug Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Migraine Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Household Use Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Migraine Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Migraine Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Migraine Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Migraine Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Migraine Drugs Market Competitive Analysis

    • 14.1 Kowa Pharmaceuticals America

      • 14.1.1 Kowa Pharmaceuticals America Company Details

      • 14.1.2 Kowa Pharmaceuticals America Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Kowa Pharmaceuticals America Migraine Drugs Product and Service

    • 14.2 Johnson & Johnson

      • 14.2.1 Johnson & Johnson Company Details

      • 14.2.2 Johnson & Johnson Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Johnson & Johnson Migraine Drugs Product and Service

    • 14.3 Eli Lilly

      • 14.3.1 Eli Lilly Company Details

      • 14.3.2 Eli Lilly Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Eli Lilly Migraine Drugs Product and Service

    • 14.4 Ethypharm

      • 14.4.1 Ethypharm Company Details

      • 14.4.2 Ethypharm Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Ethypharm Migraine Drugs Product and Service

    • 14.5 Eli Lilly

      • 14.5.1 Eli Lilly Company Details

      • 14.5.2 Eli Lilly Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Eli Lilly Migraine Drugs Product and Service

    • 14.6 Impax

      • 14.6.1 Impax Company Details

      • 14.6.2 Impax Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Impax Migraine Drugs Product and Service

    • 14.7 Winston Pharmaceuticals

      • 14.7.1 Winston Pharmaceuticals Company Details

      • 14.7.2 Winston Pharmaceuticals Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Winston Pharmaceuticals Migraine Drugs Product and Service

    • 14.8 Teva

      • 14.8.1 Teva Company Details

      • 14.8.2 Teva Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Teva Migraine Drugs Product and Service

    • 14.9 Endo International

      • 14.9.1 Endo International Company Details

      • 14.9.2 Endo International Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Endo International Migraine Drugs Product and Service

    • 14.10 AstraZeneca

      • 14.10.1 AstraZeneca Company Details

      • 14.10.2 AstraZeneca Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 AstraZeneca Migraine Drugs Product and Service

    • 14.11 Pfizer

      • 14.11.1 Pfizer Company Details

      • 14.11.2 Pfizer Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Pfizer Migraine Drugs Product and Service

    • 14.12 Merck

      • 14.12.1 Merck Company Details

      • 14.12.2 Merck Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Merck Migraine Drugs Product and Service

    • 14.13 Abbott

      • 14.13.1 Abbott Company Details

      • 14.13.2 Abbott Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Abbott Migraine Drugs Product and Service

    • 14.14 GlaxoSmithKline

      • 14.14.1 GlaxoSmithKline Company Details

      • 14.14.2 GlaxoSmithKline Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 GlaxoSmithKline Migraine Drugs Product and Service

    • 14.15 Pfizer

      • 14.15.1 Pfizer Company Details

      • 14.15.2 Pfizer Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Pfizer Migraine Drugs Product and Service

    • 14.16 Allergan

      • 14.16.1 Allergan Company Details

      • 14.16.2 Allergan Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Allergan Migraine Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Migraine Drugs

    • Figure Migraine Drugs Picture

    • Table Global Migraine Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Migraine Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Migraine Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Migraine Drugs Consumption by Country (2017-2022)

    • Figure United States Migraine Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Migraine Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Migraine Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Migraine Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Migraine Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Migraine Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Migraine Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Migraine Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Migraine Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Migraine Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Migraine Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Migraine Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Migraine Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sumatriptan Consumption and Growth Rate (2017-2022)

    • Figure Global Zolmitriptan Consumption and Growth Rate (2017-2022)

    • Figure Global Rizatriptan Consumption and Growth Rate (2017-2022)

    • Figure Global Other Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Household Use Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Sumatriptan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Zolmitriptan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rizatriptan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Household Use Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Migraine Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Migraine Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Kowa Pharmaceuticals America (Foundation Year, Company Profile and etc.)

    • Table Kowa Pharmaceuticals America Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kowa Pharmaceuticals America Migraine Drugs Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Migraine Drugs Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Migraine Drugs Product and Service

    • Table Ethypharm (Foundation Year, Company Profile and etc.)

    • Table Ethypharm Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ethypharm Migraine Drugs Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Migraine Drugs Product and Service

    • Table Impax (Foundation Year, Company Profile and etc.)

    • Table Impax Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Impax Migraine Drugs Product and Service

    • Table Winston Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Winston Pharmaceuticals Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Winston Pharmaceuticals Migraine Drugs Product and Service

    • Table Teva (Foundation Year, Company Profile and etc.)

    • Table Teva Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Migraine Drugs Product and Service

    • Table Endo International (Foundation Year, Company Profile and etc.)

    • Table Endo International Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Endo International Migraine Drugs Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Migraine Drugs Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Migraine Drugs Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Migraine Drugs Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Migraine Drugs Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Migraine Drugs Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Migraine Drugs Product and Service

    • Table Allergan (Foundation Year, Company Profile and etc.)

    • Table Allergan Migraine Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Migraine Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US